PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

Gender-affirming hormone therapy may not increase CVD risk for transgender adolescents

American Heart Association Epidemiology, Prevention, Lifestyle & Cardiometabolic Health Conference -- Presentation MP65

2021-05-20
(Press-News.org) DALLAS, May 20, 2021 — Transgender adolescents are more likely to have at least one cardiovascular disease risk factor compared to cisgender (same gender as at birth) adolescents, according to preliminary research to be presented at the American Heart Association’s Epidemiology, Prevention, Lifestyle & Cardiometabolic Health Conference 2021. The meeting is virtual, May 20-21 and offers the latest science on population-based health and wellness and implications for lifestyle.

The United States has a growing population of transgender adolescents ages 12-21 who seek medical transition gender-affirming hormone therapy. Gender-affirming hormone therapy involves taking estrogen or testosterone for transgender females or males, respectively. Previous research of cisgender adults indicates estrogen has cardioprotective effects, and an estimated 37% of healthy-weight cisgender adolescents have at least one atherosclerotic cardiovascular disease (ASCVD) risk factor.

“Gender-affirming hormone therapy is an option for transgender individuals, and yet very little research currently focuses on the transgender adolescent community,” said first author Ambur Staab, M.D.-candidate at the University of Utah School of Medicine in Salt Lake City. “Heart disease is the leading cause of mortality in the United States, and we understand, to some degree from previous research, that estrogen and testosterone can impact risk factors for heart disease. We have yet to fully study how these hormones affect heart disease risk specifically in the transgender adolescent/young adult population, and we sought to get a better understanding through this study.”

Researchers at the University of Utah conducted a retrospective analysis of 300 adolescent transgender patients who received gender-affirming hormone therapy at the Adolescent Medicine Clinic at Primary Children’s Hospital in Salt Lake City, between January 2015 and December 2020. Among the 300 transgender adolescents, 50 transgender male and 50 transgender female patients were randomly selected for analysis of ASCVD risk factors when gender-affirming hormone therapy began and after one year of treatment.

Researchers found that among the 100 transgender patients analyzed:

At baseline, 50% of transgender females and 66% of transgender males had at least one ASCVD risk factor; After one year of gender-affirming hormone therapy, 30% of transgender females and 70% of transgender males had at least one ASCVD risk factor; and While there was no significant change in ASCVD risk factors for transgender females, transgender males experienced a significant decrease in HDL cholesterol levels and significant increase in BMI for after one year of gender-affirming hormone therapy. “Gender-affirming hormone therapy appears to have greater benefits than risks for transgender adolescents and young adults,” said Nicole L. Mihalopoulos, M.D., M.P.H, chief of the division of adolescent medicine at the University of Utah and principal investigator of the study. “For some people, these findings influence their decision to not to start gender-affirming hormones during adolescence. However, without gender-affirming hormone therapy, transgender individuals may experience worse gender dysphoria, depression, anxiety and possibly increased suicidal ideations.”

These findings indicate that gender-affirming hormone therapy for transgender males may have a negative impact on some ASCVD risk parameters; however, the researchers note that baseline lab testing can help physicians counsel and educate patients about the benefits and risks of gender-affirming hormone therapy. Additionally, adverse health effects should be addressed with healthy lifestyle behavior changes first, as is standard care for any other adolescent and young adult who may have modifiable cardiovascular disease risk factors.

Some limitations of the study include a small sample size and that most patients identified as non-Hispanic white individuals; therefore, the results are not generalizable to transgender individuals from diverse racial or ethnic groups. In addition, follow-up data was only collected for one year. While researchers note the strengths in their preliminary findings, it is not possible to establish a causal relationship between gender-affirming hormone therapy and ASCVD risks factors without a larger study that includes more follow-up data and for a longer time period after treatment.

INFORMATION:

Co-authors include Amy M. Cizik, Ph.D., M.P.H. Author disclosures are in the abstract. The study was funded by the Medical Student Research Program at the University of Utah School of Medicine via an NIH training grant and University of Utah Institutional support.

Additional Resources:

Multimedia is available on the right column of release link https://newsroom.heart.org/news/gender-affirming-hormone-therapy-may-not-increase-cvd-risk-for-transgender-adolescents?preview=95c8a7535dbe60436a0523077c148845 Video perspective (via Zoom): Carl G. Streed Jr. M.D., M.P.H., an assistant professor in the Boston University School of Medicine, is co-author of Assessing and Addressing Cardiovascular Health in LGBTQ Adults: A Scientific Statement From the American Heart Association in October 2020. Gender-affirming hormone therapy may increase risk of high blood pressure Many transgender people who receive hormone therapy have unaddressed heart disease risks Changes in health care, education needed to improve LGBT heart health Discrimination contributes to poorer heart health for LGBTQ adults Ideal heart health less likely among lesbian, gay and bisexual adults For more news from AHA EPI Lifestyle Conference 2021, follow us on @HeartNewsTwitter #EPILifestyle21. Statements and conclusions of studies that are presented at the American Heart Association’s scientific meetings are solely those of the study authors and do not necessarily reflect the Association’s policy or position. The Association makes no representation or guarantee as to their accuracy or reliability. The Association receives funding primarily from individuals; foundations and corporations (including pharmaceutical, device manufacturers and other companies) also make donations and fund specific Association programs and events. The Association has strict policies to prevent these relationships from influencing the science content. Revenues from pharmaceutical and biotech companies, device manufacturers and health insurance providers are available here, and the Association’s overall financial information is available here.

The American Heart Association’s EPI | LIFESTYLE 2021 Scientific Sessions is the world’s premier meeting dedicated to the latest advances in population-based science. The virtual meeting will be held Thursday and Friday, May 20–21, 2021. The primary goal of the meeting is to promote the development and application of translational and population science to prevent heart disease and stroke and to foster cardiovascular health. The sessions focus on risk factors, obesity, nutrition, physical activity, genetics, metabolism, biomarkers, subclinical disease, clinical disease, healthy populations, global health and prevention-oriented clinical trials. The Councils on Epidemiology and Prevention and Lifestyle and Cardiometabolic Health (Lifestyle) jointly planned the EPI/Lifestyle 2021 Scientific Sessions. Follow the conference on Twitter at #EPILifestyle21.

About the American Heart Association

The American Heart Association is a relentless force for a world of longer, healthier lives. We are dedicated to ensuring equitable health in all communities. Through collaboration with numerous organizations, and powered by millions of volunteers, we fund innovative research, advocate for the public’s health and share lifesaving resources. The Dallas-based organization has been a leading source of health information for nearly a century. Connect with us on heart.org, Facebook, Twitter or by calling 1-800-AHA-USA1.



ELSE PRESS RELEASES FROM THIS DATE:

Moderate-to-high TV viewing in midlife linked to later cognitive and brain health decline

2021-05-20
DALLAS, May 20, 2021 — Spending moderate to high amounts of time watching television throughout midlife was linked to greater cognitive decline and lower gray matter volumes in the brain later in life, according to preliminary research from three studies (P149, MP24 and MP67) to be presented at the American Heart Association’s Epidemiology, Prevention, Lifestyle & Cardiometabolic Health Conference 2021 (EPI). The meeting is virtual, May 20-21, and offers the latest science on population-based health and wellness and implications for lifestyle. “While studies have shown the benefits of exercise to support brain health, less is known about the potential consequences of prolonged sedentary behavior such as television viewing ...

2016 US presidential election skewed BP, heart rhythms in those with existing conditions

2021-05-20
DALLAS, May 20, 2021 -- Notable for high levels of stress and anger, the 2016 U.S. presidential campaign and election may have increased the risk of potentially life-threatening heart rhythms and worsened high blood pressure in people with underlying cardiovascular disease who already had a history of these conditions, according to a new study published today in the Journal of the American Heart Association and in a separate preliminary study to be presented at the American Heart Association's Epidemiology, Prevention, Lifestyle & Cardiometabolic Health Conference 2021. The meeting is virtual, May 20-21, and offers the latest science on population-based health and wellness and implications ...

Palaeontology: Ancient turtle from Texas yields evolutionary insights

2021-05-20
The discovery of the oldest known North American species of side-necked turtle -- turtles that withdraw their necks sideways into their shells when threatened -- is reported in Scientific Reports this week. The findings suggest that side-necked turtles may have migrated to North America during the Cenomanian age (100 to 94 million years ago). Brent Adrian and colleagues have named the species Pleurochayah appalachius from the Greek word Pleuro (side), the Caddo word Cha'yah (turtle) and the North American Appalachian region. The fossilised remains of P. appalachius, which were discovered at the Arlington Archosaur Site of the Woodbine Group in Texas, USA, date back to the lower middle Cenomanian. They predate remains of Paiutemys tibert, a side-necked turtle species from Utah that ...

Overcoming long-term trauma can be facilitated

Overcoming long-term trauma can be facilitated
2021-05-20
How the brain deals with trauma is complex, and it's intuitive to say that we, as humans, get over trauma differently depending on if it happened a long time ago or if it was recent. But what scientific evidence do we have about the way the brain deals with short-term versus long-term traumatic memories? EPFL scientists have identified the specific regions in the brains of mice responsible for reprograming traumatic experiences towards safety, and the brain regions are indeed different and depend on whether the trauma happened recently or a long time ago. They found that they could facilitate the extinction of long-lasting traumatic memories by enhancing the activity of a primitive region of the brain called the nucleus reuniens. The results are published today in Nature ...

A brand new cocktail to fight HIV

2021-05-20
Montréal, May 20, 2021--Researchers at the University of Montreal Hospital Research Centre (CRCHUM) and Yale University have succeeded in reducing the size of the HIV reservoir in humanized mice by using a "molecular can opener" and a combination of antibodies found in the blood of infected individuals. In their study published in Cell Host & Microbe, the team of scientists, in collaboration with their colleagues at the University of Pennsylvania and Harvard Medical School, show that they were also able to significantly delay the return of the virus after stopping antiretroviral therapy in this animal model. Humanized mice are generated from immunodeficient mice that don't have their own ...

Ultra-sensitive light detector gives self-driving tech a jolt

Ultra-sensitive light detector gives self-driving tech a jolt
2021-05-20
Realizing the potential of self-driving cars hinges on technology that can quickly sense and react to obstacles and other vehicles in real time. Engineers from The University of Texas at Austin and the University of Virginia created a new first-of-its-kind light detecting device that can more accurately amplify weak signals bouncing off of faraway objects than current technology allows, giving autonomous vehicles a fuller picture of what's happening on the road. The new device is more sensitive than other light detectors in that it also eliminates inconsistency, or noise, associated with the detection process. Such noise can cause systems to miss signals and put autonomous vehicle passengers at risk. "Autonomous ...

Radar tracking uncovers mystery of where honeybee drones have sex

2021-05-20
Scientists from Queen Mary University of London and Rothamsted Research have used radar technology to track male honeybees, called drones, and reveal the secrets of their mating behaviours. The study suggests that male bees swarm together in specific aerial locations to find and attempt to mate with queens. The researchers found that drones also move between different congregation areas during a single flight. Drones have one main purpose in life, to mate with queens in mid-air. Beekeepers and some scientists have long believed that drones gather in huge numbers of up to 10,000 in locations known as 'drone congregation areas'. Previous research has used pheromone lures to attract drones, raising concerns ...

Preliminary analysis of association between COVID-19 vaccination, sudden hearing loss

2021-05-20
What The Study Did: These preliminary findings using U.S. Centers for Disease Control and Prevention Vaccine Adverse Events Reporting System data in the early phase of societal COVID-19 vaccination using two messenger RNA vaccines suggest that no association exists between inoculation with a SARS-CoV-2 messenger RNA vaccine and incident sudden hearing loss. Authors: Eric J. Formeister, M.D., M.S., of the Johns Hopkins University School of Medicine in Baltimore, is the corresponding author.  To access the embargoed study: Visit our For The Media website at this link https://media.jamanetwork.com/ (doi:10.1001/jamaoto.2021.0869) Editor's Note: Please see the article for additional information, ...

Timing of exposure to secondhand smoke, ADHD symptoms in children

2021-05-20
What The Study Did: Researchers assessed associations between prenatal, early postnatal or current exposure to secondhand smoke and symptoms of attention-deficit/hyperactivity disorder (ADHD) among school-age children in China. Authors: Li-Wen Hu, M.D., Ph.D., and Guang-Hui Dong, M.D., Ph.D., of Sun Yat-sen University in Guangzhou, China, are the corresponding authors. To access the embargoed study: Visit our For The Media website at this link https://media.jamanetwork.com/ (doi:10.1001/jamanetworkopen.2021.10931) Editor's Note: The article includes funding/support disclosures. Please see the article for additional information, including other authors, author contributions ...

Colorectal cancer screening past age 75 lowers cancer death risk for most

2021-05-20
BOSTON - Screening for colorectal cancer - the second most common cause of cancer-related death in the United States - can save lives by detecting both pre-cancerous lesions that can be removed during the screening procedure, and colorectal cancer in its early stages, when it is highly curable. Screening is most commonly performed with endoscopy: visualization of the entire colon and rectum using a long flexible optical tube (colonoscopy), or of the lower part of the colon and rectum with a shorter flexible tube (sigmoidoscopy). This week, the United States Preventive Services Task Force (USPSTF) lowered the recommended beginning age for screening from 50 to 45 for persons without a family history of colorectal ...

LAST 30 PRESS RELEASES:

Reality check: making indoor smartphone-based augmented reality work

Overthinking what you said? It’s your ‘lizard brain’ talking to newer, advanced parts of your brain

Black men — including transit workers — are targets for aggression on public transportation, study shows

Troubling spike in severe pregnancy-related complications for all ages in Illinois

Alcohol use identified by UTHealth Houston researchers as most common predictor of escalated cannabis vaping among youths in Texas

Need a landing pad for helicopter parenting? Frame tasks as learning

New MUSC Hollings Cancer Center research shows how Golgi stress affects T-cells' tumor-fighting ability

#16to365: New resources for year-round activism to end gender-based violence and strengthen bodily autonomy for all

Earliest fish-trapping facility in Central America discovered in Maya lowlands

São Paulo to host School on Disordered Systems

New insights into sleep uncover key mechanisms related to cognitive function

USC announces strategic collaboration with Autobahn Labs to accelerate drug discovery

Detroit health professionals urge the community to act and address the dangers of antimicrobial resistance

3D-printing advance mitigates three defects simultaneously for failure-free metal parts 

Ancient hot water on Mars points to habitable past: Curtin study

In Patagonia, more snow could protect glaciers from melt — but only if we curb greenhouse gas emissions soon

Simplicity is key to understanding and achieving goals

Caste differentiation in ants

Nutrition that aligns with guidelines during pregnancy may be associated with better infant growth outcomes, NIH study finds

New technology points to unexpected uses for snoRNA

Racial and ethnic variation in survival in early-onset colorectal cancer

Disparities by race and urbanicity in online health care facility reviews

Exploring factors affecting workers' acquisition of exercise habits using machine learning approaches

Nano-patterned copper oxide sensor for ultra-low hydrogen detection

Maintaining bridge safer; Digital sensing-based monitoring system

A novel approach for the composition design of high-entropy fluorite oxides with low thermal conductivity

A groundbreaking new approach to treating chronic abdominal pain

ECOG-ACRIN appoints seven researchers to scientific committee leadership positions

New model of neuronal circuit provides insight on eye movement

Cooking up a breakthrough: Penn engineers refine lipid nanoparticles for better mRNA therapies

[Press-News.org] Gender-affirming hormone therapy may not increase CVD risk for transgender adolescents
American Heart Association Epidemiology, Prevention, Lifestyle & Cardiometabolic Health Conference -- Presentation MP65